Balefire, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1750924 DALLAS, TX

Position in HALO

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$229,800

New position

Shares Held

2,936

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#489

of 664 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Balefire, LLC holds $1,269,056 across 5 Biotechnology names. HALO ranks #4 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	7,093	$385,930
2	LGND	Ligand Pharmaceuticals Inc	1,043	$329,681
3	VRTX	Vertex Pharmaceuticals Inc / Ma	479	$237,933
4	HALO	Halozyme Therapeutics, Inc. This page	2,936	$229,800
5	ANNX	Annexon, Inc.	15,011	$85,712

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$229,800	2,936	—	Shares	Sole	2026-07-07
No filing history on record for this holder in this stock.